Regeneron Pharmaceuticals REGN Q1 2026 Results Top Views on Strong Revenue PDF Solutions PDFS Q1 2026 Beat Revenue NA EPS Exceeds by Significant UK Political Uncertainty Labour Leadership Crisis Adds Risk to Market Outlook Lodha Developers LODHANS Share Down 212 Support Test at 82963 20260520 AARP and North Carolina Law Enforcement Unite to Combat Rising Cryptocurrency ATM Scams SEC Proposes Allowing Public Companies to Skip Quarterly Earnings Reports